The Pneumococcus and the Mouse Protection Test: Importance of the Lag Phase in vivo
- 1 January 1983
- journal article
- research article
- Published by S. Karger AG in Chemotherapy
- Vol. 29 (2) , 128-134
- https://doi.org/10.1159/000238186
Abstract
During development of a mouse protection test with a pneumococcus type 3 we noted the importance of the immediate post-challenge lag phase of the bacteria in vivo for the effective timing of treatment with different antibiotics. The lag phase, lasting 6–8 h after intraperitoneal challenge and parallel in peritoneium and blood, was reproducible with the same and three other strains of pneumococcus type 3. Penicillin administration during the lag phase had no effect upon survival of the mice, while a significantly improved effect was obtained after treating the mice with penicillin during the bacterial growth phase. In contrast, treatment with gentamicin or erythromycin during the bacterial lag phase was significantly more effective than administration of either drug after initiation of growth of the pneumococcusKeywords
This publication has 6 references indexed in Scilit:
- Importance of bacterial growth phase in determining minimal bactericidal concentrations of penicillin and methicillinAntimicrobial Agents and Chemotherapy, 1981
- Cefmenoxime (SCE-1365), a novel broad-spectrum cephalosporin: in vitro and in vivo antibacterial activitiesAntimicrobial Agents and Chemotherapy, 1981
- HOST MECHANISMS WHICH ACT TO REMOVE BACTERIA FROM THE BLOOD STREAMMicrobiology and Molecular Biology Reviews, 1960
- AN EXPERIMENTAL ANALYSIS OF THE CURATIVE ACTION OF PENICILLIN IN ACUTE BACTERIAL INFECTIONSThe Journal of Experimental Medicine, 1956
- THE EFFECTIVE CONCENTRATIONS OF PENICILLIN IN VITRO AND IN VIVO FOR STREPTOCOCCI, PNEUMOCOCCI, AND TREPONEMA PALLIDUMJournal of Bacteriology, 1950
- THE EFFECT OF THE SIZE OF THE INOCULUM AND THE AGE OF THE INFECTION ON THE CURATIVE DOSE OF PENICILLIN IN EXPERIMENTAL INFECTIONS WITH STREPTOCOCCI, PNEUMOCOCCI, AND TREPONEMA PALLIDUMThe Journal of Experimental Medicine, 1949